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Alzheimer's Disease, a specific type of senile dementia currently affecting 
two million Americans (66), is a disorder of memory and cognition occurring in 
middle to late life. Generally, "dementia" is a clinical term referring to 
progressive loss of cognitive functions commonly involving memory, orientation, 
abstraction and the ability to learn new tasks (71). Diseases classified as 
dementias, which affect 10-15% of those 65 and older (73), include senile 
demetias (often caused by normal aging processes or vascular disease), 
Parkinson's Disease and amyotrophic lateral sclerosis (ALS). Of the 10-15% 
of the older population stricken, ĪÌĤĬŸIŠĚof these suffer from Alzheimer's 
Disease (AD). CUrrently, the rate of new AD cases is approximately 100,000 
per year, greater than those of heart attacks and strokes. Considering the 
recent trends in demographics, the 65+ population is expected to reach 
36.6 million by the year 2000 ĜÍŸIŠĞĚ and 58.8 million by 2025 (20%), meaning 
that upwards of 5 million persons may eventually fall victim to AD (8). 
Because the symptoms of AD closely resemble those of many of the senile 
dementias, diagnosis is only possible by neuropathological exam of post-
mortem or biopsied brain tissue. However, the physical and mental effects 
are severely pronounced. The progression of the disease, which may last 
anywhere from 18 months to 27 years (average=10 years), follows a gradual 
steady decline in mental abilities, first memory then psychomotor and 
language skills (8). Personality characteristics may also be altered 
dramatically, with victims often experiencing social avoidance, fearfulness, 
paranoia or delusion, irritability and agitation (46). In many cases, verbal 
and physical aggression toward family members and caregivers is not uncommon. 
Though AD victims appear well at first, the ability to execute simple daily 
tasks such as remembering names, finding the right word, recalling having 
done something and eventually even eating becomes impaired. Ultimately 
unable to speak, think or take care of themselves, most victims end up 
dying from complications ŠȚŸȘWÙŪŦĚbedridden patients. 
CHARACTERISTICS OF ALZHEIMER'S DISEASE 
Biologically, little is known about the pathogenesis of AD because of 
problems in accurate diagnosis and lack of accepted animal models. Though 
dementias have been recognized since ancient times, this particular type 
was first identified by the German physician Alois Alzheimer in 1906 (3). 
The disease he described was a presenile dementia associated with histologic 
--
-
findings of neocortical intraneuronal fibrils and parenchymal "senile" 
plaques (34), which, unfortunately, are still the only identification 
markers we have today. Extensive studies of the neuropathological changes 
in AD have shown consistent characteristic chemical and structural changes 
in the brain, including disturbance of specific neurotransmitter systems, 
neuronal loss and the presence of neurofibrillary tangles and protein-based 
plaques. 
The first of these neuropathological changes originally obsereved by 
Alzheimer, the "senile" plaque, has since been found to consist of a 
ŸĤŠÜXŨŬÙTĚcentral core surrounded by a spherical cluster of dystrophic 
neurites and glial cells located mostly in the cerebral cortex and hippo-
campus (59). These extracellular deposits ŬȚŸĚ-pleated sheet polypeptide 
• 
fibrils are approximately 20-150uM in diameter and completely insoluble 
in all physiological fluids, indicating that VẀȘUŸĚ-amyloid accumulation 
may cause neuronal loss (71). Though these plaques occur to a small extent 
in the brains and vascular systems of normal aged humans, the quantity is 
much greater in AD, with the genesis thought to develop slowly (for decades) 
before the advent of symptoms. 
2 
A second structural abnormality specific to AD is the neurofibrillary 
tangle (NFT). Present in large numbers in the neocortex and hippocampus 
(6-40 times greater than normal aging), these structures are the most path-
ologically significant evidence of AD. Composed of accumulations of dense 
fibrous strands within neuronal cytoplasm, the NFT's exist exclusively as 
pairs of lOnm filamentous protein wound in helical fashion. These.paired 
helical filaments (PHF), because they are aberrations of normal cytoskeletal 
growth, may directly cause neuronal loss or interfere with neural signal 
and transmitter transport (72). 
Most recently, the focus on neurochemical changes has made great strides 
toward unlocking the secrets vital to developing combative drug therapy. 
While the plaques and tangles may yield information about the pathology of 
AD, it will eventually be chemical intervention that leads to a cure. Some 
of the important changes in neurotransmitter systems discovered include 
1) reductions in presynaptic markers for cholinergic neurotransmission, 
2) changes in noradrenergic systems, 3) severe decreases in somatostatin 
levels and 4) neuronal degeneration in the amygdala, hippocampal formation 
and neocortex (73). 
-3 
While the causes and effects of the neuropathological changes observed in 
AD are sketchily understood at best, specific distinguishing differences 
between AD, "regular" senile dementia (SD) and normal aging have been confirmed. 
First, SD displays a less uniform and less severe progression than AD, pro-
ducing varying symptoms in victims. Second, the neuronal loss caused by SD 
is not greater than that caused by normal aging, and is much less than that 
caused by AD. In fact, the number and location of plaques, tangles and dead 
neurons are often used as "threshold" parameters in preliminary AD diagnosis. 
Third, most of the SD changes affect the white matter, while AD almost 
exclusively affects gray matter. Fourth, the concentration changes of trans-
mitters and the imbalances observed among different neurotransmitter systems 
in AD are significantly different from those observed in SD (62,76,87). 
THE IMPLICATION OF ALUMINUM 
Considering the lack of concrete definition of the disease itself, it 
is not surprising to note how many disparate theories on the etiology of 
ŸĚ AD have been advanced. Though some point to an infectious agent or blood-
flow deficiency as possible causes, these theories have been given little 
credence (86). During the late 1980's, familial patterns of AD incidence 
led to widespread investigation of a possible genetic link. Though some 
-
AD symptoms (PHF's, senile plaques containing amyloid fibrils and amyloid-
laden cerebral vessels) were the same as those found in Down's Syndrome, 
no gene was ever discovered on chromosome 21, causing this theory also to 
be dismissed (33). Studies of WUŤŸĚ-amyloid protein involved in plaque 
formation have uncovered a specific protein sequence of 43 amino acids 
which may be directly responsible for the genesis of plaques (33,59), but 
still others argue that the plaques are a posttraumatic event. Another 
promising theory advanced recently stems from the discovery that choline-
acetyl transferase (CAT) is reduced by ĲŸȚŬĚ in AD. The subsequent reduction 
in acetylcholine mediated transmission of nerve impulses may affect memory 
formation (86). 
Based on geographic differences and correlations in the incidence of 
AD, environmental factors have also been implicated, and various "toxin" 
models proposed (66). Out of all such theories, one toxin has consistently 
- surfaced and resurfaced during the course of AD research: aluminum. 
Aluminum, one of the major components of the earth's crust and one of the 
most pervasive elements in the daily environment, is present in the air, 
in drinking water and in common foods and drugs (especially processed 
cheeses, antacids and buffered aspirins). Though we are now aware of the 
potential correlation between Al and AD, the implication of Al has had a 
rather interesting history. 
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The earliest indications that Ai could cause neural damage was the 
discovery in the 1950's that dialysis patients often suffered from 
encephalopethy, a form of irreversibly fatal dementia eventually attributed 
to high Al concentrations in the water used during the treatment process. 
These patients exhibited both an increased body load of Al and elevated 
brain Al levels, though no plaques or tangles were observed (49,79,87). 
About one decade later, a more concrete connection between ingested 
Al and AD-like symptoms llaS confirmed. For years, certain communities in 
Guam had been subject to devastating numbers of amyotrophic lateral 
sclerosis cases, with correspondingly high brain Al levels and neurofibral 
tangles. In the mid-1960's, it was discovered that the drinking water supply 
was especially high in Al and low in calcium. Since Ca deficiency in water 
could enhance Al absorption, a direct link was proposed (86). 
As a result of these "ingestion" connections, several major investiga-
tions of Al in drinking water, food and cooking utensils were performed in 
the 1970's. Because of the difficulty in quantitating and isolating the 
amount of Al ingested from specific sources, most of these studies were 
found to be inconclusive. However, one study comparing the Al concentrations 
of the drinking water in England and Wales for a 10-year period to the 
incidence of AD showed a seemingly significant correlation. The risk of AD 
was found to be 1.5 times higher where the average Al concentration was 
greater than 0.11 rng/l, compared to concentrations of less than O.Olug/l, 
but these differences in concentration were so dramatic that the increased 
risk was virtually dismissed as unrelated (36,51). 
ALUMINUM AND ALZHEIMER I S SYMPTOMS 
Following belatedly from the discovery of dialysis encephalopathy, new 
studies attempting to link brain Al accumulation to AD symptoms were under-
taken in the 1980's. Ai salts were injected directly into the subcortical 
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space or spinal cords of animals, and it was found that encephalopathy 
resulted, though the disease symptoms were different than dialysis 
encephalopathy and AD (13,32,83). Though neurofibral tangles, neural 
degeneration and mental deterioration are observed in all three diseases, 
the most significant differences are 1) the courses of neurotoxicity 
symptoms differ, 2) the rates of progression differ, with AD being the 
slowest and most universally predictable, 3) the NFT's occur in different 
locations and do not have the same structure and 4) very few plaques are 
observed in the induced encephalopathies (51,87). 
Beginning with the first identification of Al localized within AD 
plaques in 1976 (20), widespread investigation of the location and activity 
of Al in the central nervous system has led to a wealth of potentially 
useful but apparently unrelated pieces of lG1owledge. Though there is no 
known biological role for Al, its exclusive existence as Al+3 allows it 
to interrupt biochemical processes by acting as an oxidizing agent, ligand 
or foreign electrochemical transmitter. Specific Al accumulation has been 
observed to occur mainly on cellular nuclei in the brain, with the toxicity 
altered by the formation of hydrated states and ligand complexes (19). Al 
has also been found to interact with DNA, causing pH and concentration 
dependent alterations in transcription by the formation of three Al-OH-DNA 
complexes (44). Having found Al located on chromatin, it is thought that 
genetic and metabolic processes may be affected (19). 
Perhaps more importantly, Al has been found within the structures of 
both senile plaques and paired helical filaments. A study involving X-ray 
dispersion techniques showed Al and silicon colocalized in the central 
region of senile plaque cores, present as both tetrahedral and octahedral 
amorphous aluminosilicates (14,15). Because other essential elements (S,K, 
Mg,Ca,Fe) did not show focal concentration in plaques, a specific mechanism 
involving Al in the initiation of early stages of plaque formation has been 
suggested (14). 
Raised Al and silicon concentrations have also been reported in neuro-
fibrillary tangle bearing neurons in AD (14). Focal Al concentration in the 
nuclear region of tangle-bearing cells (38.4%) was found, especially in the 
hippocampus, while adjacent neurons showed no presence of Al (72). Several 
possible NFT formation methods involving Al have been proposed, one being 
--
that they may be caused by abnormal phosphorylation of 200-kd neuro-
filament proteins, a process interrupted by the formation of insoluble 
Al-phosphate complexes (37). Another theory proposes the modification of 
normal cytoskeletal components (neurotubules, neurofilaments and actin) 
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by Al located in the cytoplasm (37). A third possible method is Al induced 
protein polymerization, which could cause the assembly of highly insoluble 
aberrant protein within the perikaryon, giving rise to tangles and 
eventually destroying neurons (76). 
In addition to the possible roles of Al in producing structural changes, 
the chemical activity of Al in the brain has also been investigated. One 
important Jiscovery was that Al may induce large populations of electrically 
silent neurons, neurons that remain electrically active but whose spike 
generating mechanism is functionally disconnected from the dendrites (19). 
Such electrophysiological changes have been directly related to alterations 
in learning, memory and motor performance, and apparent correlations have 
been made between the number of silent neurons and degenerative neurons in 
the neocortex, an area largely affected by AD. 
Al +3 has been found to interfere w"ith neurotransmitter binding to 
receptor sites, especially inhibiting the activity of acetylcholine in 
neuroblastoma cells (51). It also inhibits specific metabolic processes, 
such as hexokinase activity (which is responsible for catalyzing glycolysis 
reactions in the brain), ferroxidase activity ( Fe metabolism) and other 
glycolytic enzymes associated with fast axoplasmic transport (2). 
Al+3 is known to inhibit many regulatory mechanisms, especially those 
involving calcium and magnesium. For example, Al+3 inhibits Na-K and Mg 
activated ATPase activity, disrupts ca+2 dependent electrophysiologic 
f . d . +2. ( . h +2/M +2 unctlons an lntracellular Ca regulatlon especlally t e Ca g 
ATPase calcium pump regulated by calmodulin) and may influence the Mg+2 
• 
requiring phosphate transferring systems involving ATP (2,51). 
Certain crucial membrane properties in the brain are also affected by 
+3 +3 .. d '" . . . Al . Al enhances llPl peroxldatlon ln the braln, causlng modlfications 
of lipid membrane layers and membrane properties. Al+3 binds directly to 
the phosphoryl head group in phospholipid membranes, affecting protein 
mobility and receptor activity (51). Most notably, Al+3 is thought to 
affect the properties of the blood-brain barrier, which may result either 
in the direct entry of Al+3 or interruption of the normal exchange 
functions for other essential elements (5,9,31,38,74). 
Though aluminum does not affect cerebral blood flow or blood-brain 
barrier (BBB) integrity, it does have certain specific effects on the 
.. . . +3 properties of the membrane. Blndlng dlrectly to endothellal cells, Al 
increases rigidification and fusion of membranes at concentrations of 
25uM (31). Formation of amphoteric Al complexes on the surface of the 
BBB also serves to neutralize the membrane, making it more approachable to 
other charged molecules. Electrochemically, Al+3 inhibits the closure of 
the voltage gated channels governing the passage of some molecules, while 
it selectively inhibits the saturable transport systems of others (5). 
Besides causing these alterations in BBB regulation of ion exchange, 
+3 Al may also cross itself by displacing any of several ions from their 
respective carriers, including Zn, Cd, Se, Na, Mg and Fe (5). 
In the blood plasma, where Al+3 is almost exclusively found, the ion 
is bound primarily to transferrin (58). In normal adults, the plasma Al+3 
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HŸĚ concentration is approximately 3ug/l, with a total transferrin-bound load 
of 10 ug (81). Despite the fact that raised serum Al levels have not been 
confirmed in AD, passage of Al through the BBB by a specific carrier such 
as transferrin could cause much more damage than unbound Al because it 
-
is taken directly to the site of a specific biochemical reaction. Al+3 is 
also knO'Vll to bind to lactate, citrate, phosphate and acetate in the blood-
stream, ligands which commonly carry other ions (23,47,48,57,84). Thus, 
+3 
aluminum could conceivably enter the bloodstream as Al and subsequently 
form a complex, or especially in the case of phosphates and citrates, the 
Al may enter from the gastrointestinal tract already bound. 
ALUMINUM ENTRY 
+3 lVhile many possible routes for the transport of Al to the brain have 
been considered, the most direct and most probable pathway is through the 
bloodstream to the blood-brain barrier. If this is indeed the case, the 
crucial question then becomes how the Al passes from the external environ-
ment to the bloodstream. As previously discussed, absorption of Al from the 
gastrointestinal tract has been extensively studied, , .... ith some, .... hat contra-
dictory results. Generally, the daily intake of Al from food and water 
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is 1-20 mg (51). Of this amount, ÍÌĤÎŸIŬĚis taken up by the intestinal mucosa 
and 80-90% is excreted through the membrane of the small intestine to the 
urinary tract (36,43). Thus, the net intestinal absorption estimated from 
the sum of daily urinary excretion ( 20ug) and the probable rate of tissue 
accumulation ( 2ug) is 0.1-0.5% of the Al+3 ingested orally, or at least 
1-5ug per day (36,51). 
Another important entryway of Al is through the respiratory tract. The 
average adult carries about lOmg of Al+3 in his lungs, received mainly as 
particles of aluminosilicates and poorly soluble compounds (2,51). Though 
" +3" h" the lungs have the h1ghest Al concentrat1on of all organs, most of t 1S 
is taken up by macrophages in the lung tissue and remains there indefinitely, 
eliminating the respiratory tract as a direct portal to the bloodstream. 
Considering the pervasity of Al in the environment, one potentially 
important pathway that has received little attention is the skin. Though 
the skin is considered to be virtually impermeable to metals and other 
inorganic compounds, many organic substances are known to penetrate to the 
bloodstream quite effectively, a fact utilized extensively by the pharma-
ceutical industry. ŸŸÙŨŤĚfew people regularly use dermatological preparations, 
many of the same organic vehicles are used in cosmetic products, one of 
which is used daily by most of the adult population: antiperspirants. 
Antiperspirants, the active ingredients of which are aluminum salts, also 
contain a wide variety of organic sUbstances that could possibly act to 
+3" "" enhance Al penetrat10n through the ax1llary t1ssue. 
The barrier function of the skin, which consists of epidermal and dermal 
layers, is thought to reside primarily in the outermost sublayer of the 
epidermis, the stratum corneum (Sc). This layer, also knOvffi as the horny 
layer, consists of dead keratin deposits and cornified cells and is thereby 
highly inelastic and impermeable. Underneath the stratum corneum, the 
epidermis extends through four more sublayers to a depth of 30-15 um, the 
deepest of which (the basal cell layer) is highly metabolically active. 
The overall function of the epidermis is to protect the dermis and to 
perform a major portion of the biochemical transformations on entering 
substances (34,61). 
Underneath the epidermis, beginning at a depth of 50-200 um, lies the 
dermis. The dermis consists of two major layers, the papillary dermis, 
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FIG. I.-Development of the se!.aceou, J!lanci from the follicular epithelium of the hair. From Pinkus (59), 
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At..... Diagrammatic representation of blood supply to 
ÓŨŲŸĦĚthe epidermiS. and the plexus of vessels around 
the hair Ihatt-inserts demonstrate alkaline phosphatae 
actIVity of: (A) half papilla; (B) shaft; (e) eplderrnts. 
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Fig. 1-25 Schematic depiction 01 the microcirculation 
units 01 skin. The artenal vessels are shown In while and 
the veins are black. A represents papillary dermIS, B the 
reticular dermiS, C the pilosebaceous apparatus, and D 
an eccrine sweat gland and duct. "1" identifies some ar· 
tenovenous communications at dilterent levels In the skin 
and subcutaneous tissue. (From J. M. Short. 1974. With 
pemllSSlOn. Harper and Row) 
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Fig. 2. Schematic of human, atxlominal skin showing ȘŬÜŮŬŸÙŨȘĚ diffusion barrier ŠŪĦŸĚ
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cross·section of each and their artcriallJloocl supply. 
From l.obitz and Mason (\09 (Reproduced by 
permission of Dr. Lobitz and the :\merican Medical 
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Fig. oJ. Dia'frammatic rl'prf'Semation of the mechanisms of transcapillary exchange. 1 = diffu-
sion.:.1 = transport by pinocvtosis. J. Y = ultrafiltration and lihration, oJ = 'open junctions', 
a = capillary Ilimen. h = .. ndOlhdial cl'li. c ŸĚhaseml'm rnemhran(', cI = pericapillary 
u.ue. (Reproduced with permission of. \bramson.1 
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which contains all of the microcirculatory vessels, and the reticular 
dermis (1000-3000um), which consists of fibrous collagen and is relatively 
acellular and avascular. Derived fron mesodermal origin, the dermis is a 
thick, chemically inert layer which serves mainly as connective tissue to 
support the epidermis. It does, however, contain all of the blood supply, 
nerve networks and glands of the skin. Therefore, materials exchange 
occurs exclusively in the papillary dermis, with the passage of exiting 
waste products and metabolites occurring at the basal cell interface. By 
the reverse process, entering substances may drift through the epidermis, 
be metabolized in the papillary dermis and pass directly into the blood-
stream (34,61). 
Aside from direct passage through the epidermal tissue, substances may 
also enter through several skin appendages, including the hair follicles, 
sebaceous glands and sweat glands. The hair follicles extend through the 
epidermis at a slight angle to the papillary dermis, where the shaft opens 
into a bulblike structure bathed in highly vaSCUlarized and metabolically 
active connective tissue (61). Despite the outward flux of keratinized 
cells during periods of hair growth, penetration during inactive periods 
has not been disproved. 
The sebaceous glands, whose function is to secrete sebum, an oily 
material consisting of fats that lubricates the skin and prevents moisture 
loss, are situated next to the hair follicles. The gland itself surrounds 
the upper third of the follicle and grows out into the surrounding dermis. 
The glandular duct directly empties the sebum produced into the shaft of 
the hair follicle, through which it travels to the skin. Because of the 
density and secretory rate of the sebum, however, the sebaceous glands are 
not a probable penetration route (77). 
Another class of appendages, the sweat glands, consists of two types of 
glands: the eccrine glands and the apocrine glands. In general, both types 
of sweat glands share the same structural features. They are tubular glands 
consisting of a secretory part, located immediately below the dermis in the 
subcutaneous tissue, and an excretory duct, which follows a spiral pathway 
through the dermis and epidermis and opens in surfaces of ridges of the 
skin. The secretory portion is coiled and twisted on itself, engulfed on 
all sides by blood vessels, making it a potential exchange site. Of the 
two types of sweat glands, the apocrine glands are much more inactive. 
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Larger than eccrine glands and localized in certain body areas (primarily 
the axillae), the apocrines secrete a turbid, viscous material directly 
into the pilary canal, just like the sebaceous glands. On the whole, they 
are poorly innervated and produce a relatively small amount of sweat (29). 
The primary function of the eccrine glands, which are distributed over the 
entire body surface, is to secrete water to dissipate body heat and cool the 
skin. They are tubular coiled glands, seated at the border of the subdermis 
and dermis, and whose ducts spiral through the epidermis to independent 
openings on the skin surface. Whereas apocrine secretion consists mainly 
of protein and carbohydrate waste material, eccrine sweat is 95-99% water 
and NaCl (77). 
Though several studies on the activity and structure of the eccrine 
glands have suggested penetration of surfactants to the dermal layer may 
be possible, little conclusive evidence on the modes of transport has 
been produced (42,52,55,68,78). Considering the process of percutaneous 
absorption, however, many factors favorable to establishing the penetration 
of Al from antiperspirants may be advanced. 
Traditionally, the skin has been knO'VTI to allow virtually free passage 
of water and some gases, but also to be extremely vulnerable to chemical 
attack (55). Because of its keratinized and cornified cells, the stratum 
corneum is the principal barrier to absorption. Diffusion of substances 
through the SC is not at all metabolic, but directly dependent on the physical 
properties of the membrane and governed by passive diffusion mathematics 
(61,77). According to Fick's Law of Diffusion, the penetration of a substance 
depends mainly on its permeability and diffusion constants and the SC 
thickness. Based on permeability and diffusion constants, materials that 
penetrate poorly are polar compounds, inorganic/organic salts, complex 
polymers and electrolytes. Some good penetrators are nonpolar (lipid-
soluble) compounds, substances forming hydrogen-bonds and ambiphilic 
solvents such as DMSO (77). 
The effectiveness of the SC, however, may be altered by any number of 
factors. Hydration is known to, promote transepidermal transport and increase 
the diffusion rate of most substances (55,77). Diffusion also increases 
exponentially with temperature (61). Physical or chemical injury to the 
skin, such as by solvents or detergents, may cause a secondary reduction 





of the skin surface, considered to be a form of physical injury, may cause 
upwards of a twenty-fold increase in penetration because of increased 
temperature and hydration (61). Most importantly, the vehicle in which a 
penetrant is carried may cause any number of destructive effects. For 
example, alcohols are notoriously harsh vehicles that enhance penetration 
by attacking the lipid building processes of the cell membranes. Certain 
vehicles may also affect transfollicular absorption by bringing the pene-
trant into closer contact with the follicular pore or canal (77). OVerall, 
since absorption flux is proportional to the SC/vehicle partition coefficient, 
a lipophilic solute may penetrate either faster or slower than a comparable 
water soluble substance. For low molecular weight compounds, however, the 
diffusion constant is generally higher in water than in other liquids (34). 
Once a substance diffuses through the stratum corneum, it is desorbed 
into the viable epidermis, where it is subject to the metabolizing properties 
of this layer. From there, it diffuses through the epidermis to the papillary 
dermis, where it reaches the capillary plexus and is transferred to the 
circulating blood. While some compounds cannot diffuse through the epidermis 
without biochemical transformation, the lack of dermal metabolism may 
sometimes allow passage of unchanged chemicals into systematic circulation (55). 
Depending on the chemical characteristics of a given penetrant, it may 
diffuse by several modes. Polar, water-soluble substances will diffuse 
transcellularly through individual cells and cell walls. Nonpolar, lipid-
solubles may diffuse either intracellularly or intercellularly, through 
the lipid material filling the interstitial spaces. The principal pathv2Y 
for 'later-soluble nonelectrolytes is transcellular, with the principal 
diffusion resistance being hydrated intracellular keratin. Lipid soluble 
compounds diffuse by different, specific mechanisms. Usually, lipophilic 
solutes will segregate into and diffuse through lipid regions, though the 
exact location of lipid pockets in the epidermis are not knowm (55). 
For aluminum, which is not lipid soluble in either the metallic or ionic 
form, the number of possible penetration sites is limited. Having ruled out 
the sebaceous and apocrine sweat glands as absorption sites, penetration 
must occur through the hair follicles, eccrine sweat glands or unbroken 
stratum corneum. The hair follicles, though a viable pathway for some 
small organic molecules,are usually filled with keratin and sebum, Ivhich 
--
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would readily prevent diffusion of a metal ion. In the case of the eccrine 
+3 
s,,,eat glands, it is possible that Al may penetrate to the secretory cells 
by a sort of electrochemical gradient caused by the ionic flow of Na+ (52, 
64). Also, the intraepidermal duct ,vall has its own lining epithelium vlhich 
may have a higher permeability than the SC (55). Though penetration through 
the unbroken SC is not likely for an electrolyte, conversion to a lipid-
soluble compound or action of a strong vehicle could greatly increase the 
permeability of Al, allowing it to follow a passive diffusion route and enter 
the circulation at the capillary endothelium (55). 
Because the key to Al penetration seems to be its lipid-sOlubility, the 
presence of organic substances with which to form Al complexes becomes very 
ÙȘŲŸŬŲWŠŪWĦĚ From the secretion of sebum and eccrine/apocrine sweat, the skin 
is constantly covered with a film of surface lipids, primarily a fine emulsion 
of fats and ,,,aste products in cholesterol and ,,,ax alcohols. The composition 




ĲĪĤĲŸIŬĚwater, NaCI, urea 
Glucose, lactic acid 
ŒÙŸŠÜÙŸVĚŁĢĿHĻGŸÍMĚ +2 
Na ,CI , K , Ca , Mg , SO 2- PO 3-, Fe+2 





















Though no specific Al complexes have been observed to directly penetrate 
the SC, metals are knOlm to form lipid-soluble complexes with fatty acids 
to form metal oleates, both inside and outside of the body (77). In 
addition, other heavy metals have been sho,m to penetrate percutaneously 
and enter systematic circulation, including Hg, Pb, Sn, CU, As, Bi and 
Ag (61, 77). 
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Recalling that skin permeability is greatly enhanced by hydrolysis, 
alcohols, occlusion and injury, the potential for Al absorption is even 
stronger in the case of antiperspirants. The active ingredients used in most 
antiperspirants are simple Al salts (AlC13 6H20 and Al2(S04)3 18H20), basic 
Al-halide salts (Al2(OH) (X) , where m+n=6), basic Al/Zr salts (Al2(OIf) (Cl) m n m n 
ZrO(OH)Cl glycine) and basic complexed Al salts (Al chlorohydrex propylene-
glycol, Al chlorohydrex polypropylene glycol). Of these active Al complexes, 
the most commonly used are AlC13 6H20, Al2(OH)m(Cl)n ' Al/Zr chlorohydrex 
and Al chlorohydrex PG (52). 
Several theories on the possible modes of effectiveness of these compounds 
have been proposed, including 1) blocking of the sweat gland, 2) making the 
walls of the sweat duct permeable to sweat and 3) reduction of sweat pro-
duction in the gland (41). Presently, the prevailing hypothesis is that 
antiperspirants have an astringent effect which acts to shrink shut the 
pore of the sweat gland, or to precipitate protein and form a keratin 
plug \.,rhich obstructs the flm.,r of sweat to the skin surface (52). Relatively 
speaking, the effectiveness of the various Al compounds in preventing 
sweating may depend on their ability to penetrate the eccrine sweat duct. 
Studies involving transmission electron micrography and tape-stripping of 
duct openings have sho,vn that AlC13 penetrates at least to the level of 
the intraepidermal duct, while aluminum chlorohydrate inhibits sweat gland 
activity as deep as the viable epidermis. Aluminum-zirconium complexes have 
the most superficial but most prolonged antiperspirant effect, inhibiting 
50-60% of surface eccrine activity and lasting as long as 78 days per 
application (52). 
Considering the known ability of the aluminum salts to penetrate at 
least the eccrine glands, the constant contact of high Al concentrations 
• 
with the skin would favor the establishment of diffusion equilibrium. In 
fact, absorption through the appendages (also known as shunts) may even be 
likely, since electrolytes do not penetrate the stratum corneum well. 
Returning to the concept of passive diffusion matehematics, the rate of 
penetration of a surfactant will at first increase, eventually reach a 
steady state if the external concentration is maintained, then will slowly 
decrease as the surface concentration decreases. For shunt diffusion, 
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overall ionic transport rate is low and nonselective, meaning that it is 
almost always favored for slowly diffusing substances (such as hydrated 
Al+3 ). Because of the lag time in achieving the diffusion steady state, 
however, the penetration of ions and nonelectrolytes with low lipid sol-
ubility may actually be favored early and late in the penetration process. 
Though the diffusion rates of poor penetrators are slow, they remain 
relatively constant, meaning they will be more likely to penetrate while 
the rates of other stronger penetrators are equilibrating. If a high 
surfactant concentration is maintained, shunt diffusion of ions may even 
be high during the steady state (34,42). Theoretical predictions of the ionic 
diffusion rate in the eccrine duct indicate that Al(H20)6+
3 penetrates 
relatively quickly, with half the applied concentration reaching a depth 
of 0.2rnrn in 20 minutes under occluded conditions. If the applied solution 
is allowed to concentrate by solvent evaporation, 1% of the applied 
concentration will penetrate to 2rnm within 50 minutes (41). with an average 
application dose of 0.4-0.8 g antiperspirant and average product Ai con-
tent of 10-15% (unpublished data), upwards of 0.5 mg Al per application 
may penetrate to the papillary dermis at these rates, easily comparable 
to the 1-5 ug absorbed daily by the gastrointestinal tract (36,43,51). 
Besides the high aluminum content, antiperspirants also contain many 
compounds that cause occlusion and injury. In addition to the astringent 
and blocking properties of the Ai salts themselves, it is also thought 
that the hydroxide gel used as a base for most preparations effectively 
plugs almost all of the axillary pores (52). Almost all the antiperspirants 
contain large percentages of alcohols, vehicles whose abrasive properties 
unquestionably enhance penetration. Most preparations contain 25-75% water 
as well (unpublished data), which serves to hydrate the stratum corneum, 
causing it to swell and subsequently reducing the outward flux of sweat (52). 
Aside from the shunt diffusion of Al+3 , many of the matrix components in 
antiperspirants could conceivably promote tissue absorption. Though the 
ionic mobility through the tissue is limited by the polyhydration of Al+3 
and its ion charge interaction with other fixed and mobile charges, the 
species does have a diffusion constant comparable to Na, K and Br (k = 
10-6 cm/h) (34). Coupled with a small molecular weight organic ȘŬÜŮŬŸŪTHĚ
the lipid solubility would greatly increase, allowing the Al+ 3 to penetrate 
--
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by any of the primary SC permeation routes, or even a specific lipid 
mechanism. Some of the most common matrix components and their functions 
are: 
Vehicles 




ethyl alcohol, stearyl alcohol 
propylene glycol (PG), polypropylene glycol (PPG), 









hydrogenated castor oil 
isocetyl alcohol 
Drying agents talc 
Fragrances natural oil extracts 
(6,52) 
Al(lll) CHEMISTRY 
While the solution chemistry of Al+3 has been extensively documented, 
few fully collaborating results have been produced (1,12,23,47,52,25,84,85). 
+3 Because Al may act amphoterically, its behavior in aqueous solution is 
affected by innumerable factors and is thereby highly unpredictable. For 
the most part, Al+3 chemistry is dominated by hydrolysis ana oxidation 
+3 
reactions. Though Al has a relatively low ligand exchange rate, it readily 











Though these processes attain rapid, reversible equilibria, they 
directly depend on pH. At pH 5.0, the stable ionic species Al(H20)6+
3 
perdominates. As the pH increases from about 5-6.5, the successive depro-
tonations to Al(OH)+2 and Al(OH)+ occur. At neutral pH, the aluminum 
hydroxides congregate to form a gelatinous Al(OH)3 precipitate that will 
redissolve in basic solution to tetrahedral Al(OH)4-. Once basic pH is 
reached, however, the time-dependent formation of some polynuclear species 
occurs (12,52). Aqueous aluminum systems are often characterized by the 
neutralization ratio, n, which is simply the OH/Al ratio. For systems 
in which n 2.5, small mononuclear and dimeric ion species form first, 
. +4 +5 followed by the small polynuclear specles A12(OH)2 and Al3 (OH)4 . 
After a few hours, large stable polynuclear species, predominantly 
+7 Al1304 (OH)24 ,may form depending on the exact n, temperature and rate of 
OH addition. Over a period of weeks, an undisturbed solution may form 
high molecular weight polymers or amorphous solids, such as gibbsite or 
bayerite (52). 
. . f +3. db' Overall, the Solutlon chemlstry 0 Ai lS governe y n, solutlon 
concentration, ionic strength, temperature, pH, concentration of other 
- -2 ions (especially Cl , S04 and N03), time, form and rate of OH addition 
and equilibrium status (1,52,56,75). 
Whether the chemistry of Al+3 changes in the presence of other organic 
and inorganic compounds remains to be seen, however, as few such studies 
have been reported. While the solution chemistry of the aluminum salts 
used to manufacture antiperspirants has been sufficiently documented (12,52), 
no literature references on the behavior of Al in the actual product matrix 
have been found. Considering the potential of an environment containing 
high Al concentrations, abrasive vehicles and lipid-soluble components to 
promote absorption, investigation of the chemistry involved could produce 
some of the information needed to establish a "new·" route to the blood-
stream. In this light, the task of this project was to first quantitate 
the amount of Ai in various types of preparations, then to attempt to 
separate some of the smaller organic compounds in the matrices and 




EXPERIMENTAL METHODS AND RESULTS 
I. Selection of Samples 
Six brands of commercial antiperspirant products were chosen on the basis 
of the main active ingredient, the matrix components and mode of application 






















II. Digestion of Wet Samples 
Major Matrix Components 
Diisopropyl adipate,cyclomethicone, 









isodecyl oleate,Mg-Al silicate 
In order to perform quantitative analysis on the samples, it was necessary 
to bring them into aqueous solution by digestion. Heating for 15 minutes to 
2 hours in 10-20 ml concentrated RN03 and H2S04 did not completely dissolve 
any of the samples, instead forming "gummy" solid lumps. The addition of 
5-50 ml ĨŸÍŬĚH202 to the digestion mixture improved dissolution somewhat, 
but only after extensive strong heating (1-3 hours). 
Noting that RN03 and H2S04 woulc possibly interfere with later AA 
experiments, HC104 was used at all the conditions previously tested, with 
little improvement in results. ŸŸÙŨŤĚsome of the samples almost completely 
dissolved, some still contained gummy solids or flaky solid precipitates. 
Some solutions, though apparently dissolved, also formed gelatinous or solid 
white precipitates upon the addition of water, especially at temperatures 
higher than room temperature. 
18 
Next, to decrease the required heating time, the sample size was decreased 
from 0.5-2.0 g to 0.1-0.2 g. The samples were first treated with 1-3 ml HCI04 , 
stirred at room temperature or very low heat for 5-15 minutes, until all of 
the solid dissolved. 2-5 ml 30% H202 was added, and the solutions stirred 
vigorously at medium heat until all of the organic film and gummy solids 
diSSOlved, approximately 5-10 minutes. Additional peroxide was added to 
some samples that were not colorless to insure complete oxidation. The 
solutions were allowed to cool to room temperature and brought to volume 
with deionized water. Optimal digestion procedures for each product are as 
follows (for 0.1 g samples): 
HCI04 Stir Slight H202 
Medium Final Solution 
(ml) cool (min)heat (min) (ml) heat (min) 
Arrid 3 7 8 1 10 clear ,colorless 
ŁŸĚ 4 - 2 4 6 clear ,colorless 
Dial 3 - 5 2 10 clear ,colorless 
Secret 2 - 10 2 15 clear,colorless 
ŐŸŤĚ 4 - 5 1 5 clear, colorless 
Tussy 2 - 5 1 5 clear ,colorless 
III. water Content of Samples 
To determine the water content of the products, 1-4 g samples were dried 
in an electric oven at temperatures of 100-1250 C for periods of 10-210 hours. 
Samples were weighed out and placed in predried weighing bottles, partially 
covered with lids to prevent splattering. Three trials were performed, 
increasing the drying period each time. Changes of less than 5% occurred for 
some of the samples (Arrid, Ban and Tussy), while the weight loss for the 
others continued to increase with increased drying time. 
• 0 At WŤÜŮŤŲŠWŸŤVĚof 100-125 C, no components other than water should have 
evaporated, based on published boiling points of the product ingredients. 
Though all of the brands contained alcohols, which might be expected to 
boil at less than 125e C, these alcohols (primarily stearyl, cetyl and 
isocetyl) consist of relatively large organic parents, raising their 






o The maximum water content determined for each brand at 110-115 C was: 
Drying Time (hrs} Water Content (%) 
Arrid 210 49.1 
Ban 139 79.2 
Dial 210 56.3 
Secret 139 78.3 
Sure 210 58.4 
Tussy 139 76.3 
IV. Digestion of Dried Samples 
In order to compare the relative aluminum contents of the dried samples 
to those of the wet samples, digestions of the oven-dried samples were also 
performed. Three sets of digestions, run at the various conditions and 
parameters previously described for the wet samples, showed that the 
optimum procedure was again slight heating in minimal HCI04 then medium 
heating with H202 . However, additional difficulties were experienced with 
some of the samples, due primarily to the hardening and/or gelling caused 
by drying. 
Each dried sample was mixed and around either into a rough powder or a 
viscous paste, depending on its characteristics. The Ban, Dial and Sure samples 
dried to extremely hard solid chunks, while the Arrid, Secret and Sure samples 
dried to oily, gummy pastes, making them difficult to mix to consistent 
composition. Approximately 0.075-0.150 g samples were digested by the 
following procedures: 
HCL04 Heat HCL04 Heat H202 Heat Final Solution (rnl ) (min) (rnl ) (min) (rnl ) (min) 
3 slight 3 medium 4 medium clear, colorless 
7 10 10 small white flakes 
3 slight 2 slight clear, colorless 
15 5 
3 slight 5 medium clear,colorless 
15 10 flat white flakes* 
Secret 3 slight 3 slight clear,very Sllghtly 
1Q 5 
Sure 5 slight 3 s1.10 
15 med.15 
Tussy 5 slight 10 slight 
10 5 
*Solutlons flltered on Whatrnan 54-grade ash fllter paper 
after addition of water. 
yellow 
clear ,colorless 






v. Aluminum Content of Wet and Dried Samples by FAA 
Standard aluminum solutions were prepared from Spex Plasma Emission 
Spectroscopy aluminum standard (1000 ppm) and deionized water. 50ul ĨŸȚŬĚ
H20 2 and 100ul İŸȚŬĚHCL04 were added to each standard to approximate the 
matrices of the digested samples. All absorbance measurements were done 
20 
on a Perkin-Elmer Model 306 Atomic Absorption Spectrophotometer with a 
nitrous oxide-acetylene flame. The absorbance wavelength used was 309.3nm, 
at a slit width of 3(0.4 rum). Standards ranging in concentration from 0.5-
50.0 ppm were run, and the linear working range determined to be 5.0-50ppm. 
Concentrations below 2.0ppm were not detectable. 
Two sets of absorbance readings were taken for each digested wet and dry 









































Standard additions were also run on each set of samples to determine 
whether matrix interferences were affecting the results. 10ml standard 
solutions were prepared from 5m1 digested sample, 100ul H202 , 100ul HC104 , 
deionized water and stock ŸŨẀÜÙŪẀÜĚspikes of concentrations Ox,lx and 2x, 
where x=50 ppm. The aluminum contents of each solution by this method were: 




















Comparison of the results obtained from the calibration curve and 
standard additions methods show that interferences affected the absorbance 
of each sample differently. As would be expected with organic matrix 
interferences, the aluminum content of both the wet and dry Tussy samples 
and the wet Ban sample were higher by standard addtions. For all of the 
other samples, the aluminum content was found to be significanyly higher 
by the calibration curve, indicating some component was present in the 
standards that was not present in the samples. 
Since any viscosity, ion mobility or hydrolysis problems should have 
been prevented by the HC104 in the standards, these factors were ruled out 
as possible interferences. Though the nitrous oxide flame should have been 
hot enough to vaporize all of the organic compounds in the samples, as well 
as refractory aluminum oxides, chemical interferences would also seem to be 
discountable. 
Because the pH of the standard and sample solutions may have affected 
the chemistry of the Al+3 ions in solution, the pH of each was measured on 
an Orion Combination 501 Digital Ionalyzer. While the readings showed 
differences of up to 0.7 pH units between the standards and samples, the 
pH's of all the solutions were easily acidic enough to insure the exclusive 




































Considering all of these factors, the most probable cause of the observed 
interferences may have been simply the predominance of organic compounds in 
the products, which could have affected the nebulization rate or suppressed 
the absorption of energy by the aluminum atoms in the flame. No reported 
ionic interferences for aluminum determinations were present in any of the 
products. 
VI. Aluminum Content of Wet and Dried Samples by ICP-EM 
To overcome the observed interference effects in the FAA analyses, the 
aluminum content of each wet and dried sample was also determined by ICP-EM. 
All emission measurements were made on a Perkin-Elmer 5500 Inductively 
Coupled Plasma system. The wavelength used was 396.2 nm, at a slit width 
of 0.2 nm, gain of 325-350 and reading time of 0.2 seconds (averages of 
every ten readings were recorded). Originally, the primary aluminum emission 
wavelength of 309.8 nm was used, but secondary line interference was 
experienced. 
Several runs of standards and sample solutions were tried at various 
parameters, with the optimal conditions being those described above, along 
with a viewing height of 1-2 mm. Standard solutions were prepared from the 
Spex stock at concentrations of 5-50 ppm, with 250 ul HCI04 and 250 ul 
H202 per 100 ml. Though aluminum concentrations of 0.5 ppm were observable, 
the linear working range was 5-30 ppm. The average aluminum contents of the 












































Unexpectedly, the aluminum contants found by rcp were 1/2 to 2/3 lower 
than those determined by FAA for every sample. Assuming that matrix inter-
ferences had reduced the previously observed concentrations, the aluminum 
contents should have been 5-25% higher. The fact that they were lower 
indicates one of several possible differences occurred: 1) the age of the 
solutions affected the aluminum chemistry (the FAA solutions were 3 months 
old, while the rcp solutions were less than one week old), 2) some of the 
matrix components actually enhanced the observed absorption in the flame, 
which might also explain the lower concentrations by standard additions or 
3) secondary emission lines by other ions decreased the aluminum signal in 
the rcp experiments. OVerall, considering the high temperature of the plasma, 
the rcp results were probably more reliable. However, one other factor that 
was noticed during the rcp experiments was that the deionized water used to 
make the solutions contained about 3 ppm Al, necessitating blank corrections. 
Standard additions were also run on all of the wet samples, with these 
results: 
Em!! %Al in Original Sa!!!]2le 
Arrid 84 9.6 
Ban 121 6.6 
Dial 40 5.5 
Secret 43 3.6 
Sure 40 6.2 
Tussy 48 6.7 
By this method, the aluminum contents were found to be 3-4% higher 
than by the standard curve, which was somewhat unexpected since no matrix 
interferences were anticipated. These findings show either that some secondary 
ionic emission interference may have occurred, or that the relative blank 
--
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readings were not precise. When the standard additions solutions were 
prepared, they were brought to volume by different amounts of vlater, meaning 
that the blank aluminum concentration was not exactly the same for every 
solution. At such small concentrations and volumes (10ml) , differences of 
hundreds of microliters may have been significant. 
VII. Daily Application Doses 
The average daily antiperspirant application doses (both axillae) for 
Sure roll-on and Mennen solid were recorded for adult subjects for a period 
of one week. For the roll-on, the range was 0.5117-0.8178 g/day, with an 
average of 0.644 g/day. For the solid, the range was 0.260-0.700 g/day, 
with an average of 0.445 g/day. At an average aluminum content of 6%, 
the amount of aluminum applied daily is approximately 25-50 rng/day. 
VIII. Solubility of Wet Samples in Organic Solvents 
Anticipating infrared, GC and HPLC analysis of the products, the 
solubility of each in methanol, carbon tetrachloride, dichloromethane, 
ethanol and acetonitrile was tested. Approximately 1-3 g samples were 
dissolved in 2-5 m1 solvent and shaken vigorously. Relative solubilities 
and characteristics were the following: 
Methanol 
SOlubility Characteristics 
Arrid sl.sol. cloudy white suspension 
Ban very sol clear sOlution 
Dial mod. sol. cloudy yfhi te solution 
Secret sl.sol. cloudy white sol'n,surface film 
Sure sl.sol. dense white suspension 





Arrid sl.sol. white gelatinous emulsion 
Ban insol large oily vlhi te droplets 
Dial sl.sol. even emulsion 
Secret insol. large oily white droplets 
Sure sl.sol. thick whlte emUlSlon 




Arrid mod. sol. slightly cloudy vlhlte Solutlon 
Ban sl. sol. clear sol'n,whlte surface S011d 
Dial sol. clear sol'n,white surface solid 
Secret insol. cloudy white sol'n,small olly drople-cs 
Sure insol thick cloudy white solution 
Tussy mod. sol. clear solin, white surface SOlld 
Ethanol 
Solubility Characteristics 
Arrid 51. sol. thick whlte suspenslon 
Ban very sol. clear Solutlon 
Dial mod. sol. slightly cloudy white Solutlon 
-- Secret 51.501. opaque white solution 
Sure 51.501. opaqlle white solution 
Tussy sol. clear sclution 
ACN 
Solubility Characteristics 
Arrid lnsol. very sllgnt Q1SSOJ.utlon OI SOllO 
Ban 51.501. thin white suspension 
Dial 51.501. thin white suspension 
Secret mod. sol. opaque white solution 
Sure 51.501. thin white suspension 




IX. Infrared Analysis of Antiperspirants 
Infrared spectra of the products were taken on a Nicolet 580ZDX FT-IR 
-1 
spectrophotometer at a resolution of 4 em . Standard NaCl salt plates were 
used for all of the neat spectra, onto which a thin film of antiperspirant 
was allowed to dry. The sample compartment was sealed and purged with 
nitrogen gas for at least one minute prior to each scan, and ten interfero-
grams were collected before the fourier-transform. The infrared spectra 
and a listing of the major bands for each are given on the following pages. 
Comparison of the observed bands for the products to the published data 
for aluminum hydroxide chloride solutions (75) and to standard (Sadtler) 
infrared spectra for some of the matrix components showed few similarities. 
For aluminum hydroxide chloride solutions, the bands reported were: 











bridging Al-OH-Al stretch 
bridging stretch 




Though most of the spectra suffered from poor resolution, a prominent 
Al-O-H band was observed for all of the samples except Dial and Secret, 
and at lower intensity for those products containing Al/Zr complexes. 
Due to broad OH bands on every spectrum, none of the Al-OH-Al bridging 
bands were observed between 3100-3500 em-1 . The unassigned band at 790 em-1 
was observed on all spectra. 
Some prominent spectral features of organic matrix components were also 
present for most of the products. The series of small sharp peaks between 
1200-1500 em-1 characteristic of stearyl-based compounds were observed for 
-1 Arrid, while strong Al-stearate "doublets" at 2925-2950 cm were observed 
for Dial and Secret. The Ban and Dial spectra exhibi.ted sharp "triple" 
peaks at 2850 em-1 similar to those for glycerin and propylene glycol. 
-1 The bands for Secret between 1000-1400 em almost perfectly matched the 
ethylene glycol spectrum. 
-27 
In order to use infrared spectra as qualitative or quantitative tools 
in the analysis of antiperspirants, the spectral resolution should be 
improved. The most prominent and universal band to utilize for identification 
and quantitative analysis of Al contents is probably the Al-O-H band at 
1080 em-I, since this chemicalinteraction would be expected to occur in 
most solvents, especially alcohols. However, the spectra obtained by the 
present methods were not reproducible or resolved enough in this region. 
In an attempt to achieve better resolution, samples dissolved in 
methanol, CC14 and dichloromethane were analyzed in a liquid cell equipped 
with NaCl plates and having a cell pathlength of 0.1 mm. Solvent background 
spectra were taken prior to each set of experiments and subtracted from the 
sample spectra. This method did not work well for the CH2C12 and CC14 
because the diameter of the cell was too thick and good resolution of the 
background spectra could not be achieved. A reasonable background was 
obtained for methanol, but the subtraction process was plagued by several 
problems, one being impurities in the solvent and another being inconsis-
tencies in spectral intensity. Though the methanol should not have 
evaporated from the liquid cell, consecutive runs of equal intensity were 
rarely observed. As a result, most of the spectral features were lost upon 
subtraction. In addition, dissolved sample concentrations high enough to be 
observed through the methanol spectrum could not be produced without causing 
precipitates or emulsions in the solutions. 
Intending to determine whether any organic components had been driven 
off during the drying process, or at least to eliminate water bands from the 
spectra, the dried samples were analyzed by both liquid and mull techniques. 
A few spectral features were observable for methanol solutions, but the 
solubilities of the dried samples were even less than the wet samples, producing 
mainly methanol spectra. Nujol mulls of each sample "I.iere prepared and spread 
thinly on NaCl plates. A mineral oil background was subtracted from each 
sample spectrum. Sample concentrations in the mulls were apparently higher 
than in the methanol solutions, as the resultant spectra exhibited features 
distinct from those of the background. However, spectral resolution was too 
poor to reliably identify any of the bands. 
Major Infrared Bands for Antiperspirant Samples (frequency in em-I) 
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X. GC Analysis of Antiperpirants 
To dtermine if the antiperspirant matrix could be separated into small or 
medium molecular weight organic compounds, 1-2 g samples of Ban rOll-on were 
dissolved in a minimum of methanol and run on a GowMac Series 150 Thermal 
Conductivity Detector gas chromatograph. OUt of all the products, Ban was 
chosen because it was the only one that dissolved completely in any of the 
organic solvents tested. Though some of the others dissolved sparingly in 
methanol, filtering removed most of the product from solution. 
The samples were run on a 15% Carbowax 20M (polyethyleneglycol) column at 
a helium flow rate of 120rnl/min. Chromatographs were recorded at temperatures 
from 60-175c C. The methanol peak occurred at anywhere from 55-135 seconds, with 
retention time decreasing consistently with increasing temperature. At temp-
ŸĚ e 
eratures from 60-90 C and 105-150 C, one large methanol peak and one smaller 
broader peak were observed. This second peak emerged approximately 120 seconds 
after the methanol peak, and could not further resolved at any temperature. 
The chrometographs taken at ĲÌĤÍÌŸĿĚcontained these two primary peaks and 
sometimes two or three very broad and shallow peaks at times of 3-5 minutes. 
At temperatures above 150°C, only a broad methanol peak was observed, which 
completely obscured the second peak. 
From these preliminary results, the best temperature for separation at this 
flow rate seems to be about 90°C. The broad trailing shape of the second peak 
and the fact that it was obscured by the methanol at 150°C indicate that it 
probably represents several compounds with boiling points below 130-135e C. 
Since Ban contains no alcohols, this second peak was probably water, along with 
some fragrance elements or EDTA (used as an ion complexing agent). The other 
antiperspirant matrix ingredients were stearyl(octadecanoic acid) ethers and 
polypropylene glycol, of which only ethers and glycol(ethanediol) have boiling 
points below 175°C. Considering that the ethanediol should dissolve fairly 
readily in methanol, the broad shallow peaks observed in some of the chromato-
graphs ĜĲÌĤÍÌĪŸĿĞĚ may have been due to glycol fragments. Even if the stearyl 
ethers dissolved slightly in the methanol, the compound pieces would still be 
too bulky to emerge in 3-5 minutes. 
XI. HPLC Analysis of Antiperspirants 
A saturated solution of Ban roll-on in methanol was run on Isco Model 23S0 
high pressure liquid pumps equipped with a v4 deuterium lamp absorbance 
detector and an Alltech Asorb C18 cartridge (lSOmm x 4.6mm, cat.no. 28841). 
All experiments were performed at the following parameters: 
Offset 
Min. peak width 
Min.baseline duration 
Peak detection sensitivity 











Chromatographs of the antiperspirant solution were produced using various 
solvents, eluent ratios and flow rates, with the best resolution obtained at 
8S% methanol/1S% water and 1.2 ml/min. Acetonitrile/water and isopropanol/water 
solvents were also tested, but neither yielded good separation. Because the 
sample was only moderately soluble in ACN, filtering reduced the concentration 
too low to be able to distinguish the peaks from the background noise. In the 
case of isopropanol, the sample was completely soluble, but an extremely noisy 
baseline consistently occurred at every eluent ratio (30/70 to 70/30), flow 
rate (1.0-1.S ml/min) and sensitivity (0.OS-1.0) tested. Periodic spikes in 
the baseline were observed at each pump stroke, after which the pressure would 
drop 30-40 psi. 
Suspecting that a combination of isopropanol viscosity and a plugged column 
may have been causing the baseline difficulties, the column was replaced with 
an Alltech Econosphere C18 su cartridge (2SOrnm x 4.6mm, cat.no.71011). The 
sample was run at several isopropanol/water solvent ratios, with no improvement 
in results. In addtion to the pump fluctuation peaks, occasional bursts of air 
or solute from the column also caused large spikes. Conditioning the column 
• 
w"ith isopropanol for 30-4S minutes did not eliminate any of the spiking, so the 
original column was reinstalled. 
For the experiments using methanol/water solvent, the sample was analyzed 
at every ratio between 30/70 and 90/10 (at S% increments). The water used 
initially was Millipore-filtered, degassed and buffered in O.lM HOAc to pH 3.S. 
Though some baseline noise and occasional spiking occurred, the pump pressure 
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fluctuations were less than 10 psi, and the sample peaks were distinguishable 
from the baseline down to a sensitivity of 0.05. With the buffered water, the 
best separation was obtained using 80 meth/ 20 water at 1.2 ml/min, with at 
least twenth peaks occurring between 80-450 seconds. This same ratio was run at 
1.0 ml/min, with some loss of resolution between the smaller peaks but increased 
intensity for others. Under these conditions, only 15 peaks were observed from 
80-600 seconds. 
Having determined that methanol/water ratios of at least 80/20 were needed 
for separation, ratios of 80/20, 85/15 and 90/10 were run using unbuffered 
HPLC water (pH 6.2). Since the dissolved antiperspirant solution had a pH of 
3.9, it was expected that the buffered water used previously should have given 
optimal separation. However, much better resolution was achieved using the 
unbuffered water, though only 14-15 peaks occurred during the first 600 seconds. 
Flow rates of 1.0, 1.2 and 1.5 ml/min were tried at each of the three solvent 
ratios as well, with 1.2 ml/min again producing the best separation and most 
symmetrical peaks. The average number of plates for the peaks were rather poor, 
at 500-2000, indicating the column may be deteriorating. 
XII. Proposed Experimentation 
Having developed successful methods for drying the samples, digesting them 
and determining the aluminum content by ICP, the separation of the antiperspirants 
into their smaller organic components is currently the most important goal. To 
this end, further HPLC analysis of the samples is suggested, eventually leading 
to the collection of eluent fractions, identification of the compounds contained 
in each by infrared or NMR analysis, and quantitation of the aluminum contents 
of each. However, several possible improvements in the separation technique 
must first be explored: 
1) Elimination of baseline noise and spikes 
2) Reproducibility of chromatographs 
3) Improving the number of plates to at least 10,000 
4) Use of a new CIS column, or Cs or ion-exchange columns 
Past the successful separation and collection of fractions, the infrared 
sampling process would need to be improved or the samples analyzed on another 
instrument to achieve the resolution needed to use the spectra for structural 
identification and quantitative analysis. NMR might also be used to identify 
small matrix components if the fractions were not too complicated. 
-,-
Further , if any Al-organic compounds are identified in the antipers-
pirants, the effects of pH variation and sweat on the chemistry might also be 
investigated. Ultimately, physiological studies of the actual permeation 
capabilities of aluminum compounds through the axillary tissue and glands 
would be necessary to determine if aluminum in antiperspirants may actually 
be linked to Alzheimer's Disease. 
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